Archives of Gynecology and Obstetrics

, Volume 286, Issue 1, pp 155–159 | Cite as

Adenosine deaminase activity in patients with ovarian neoplasms

  • Ibrahim Ferhat Urunsak
  • Umran Kucukgoz Gulec
  • Semra Paydas
  • Gulsah Seydaoglu
  • Ahmet Baris Guzel
  • Mehmet Ali Vardar
General Gynecology



The aim of this study was to investigate the serum and peritoneal fluid adenosine deaminase (ADA) activity in patients with benign and malignant ovarian neoplasms.


This is a prospective cross-sectional study performed in Cukurova University, Department of Gynecologic Oncology. Eighty-four patients with ovarian mass were included in this study within 13 months. The levels of serum and peritoneal fluid ADA levels were measured and compared in patients with benign and malignant ovarian neoplasms and also low- and high-grade malignant tumors.


Serum and peritoneal fluid ADA levels were found to be significantly higher in patients with ovarian cancers as compared with benign ovarian tumors (p = 0.001). Additionally, ADA levels were found to be significantly different according to the histopathological subtypes and grade of ovarian cancers. However, there was no significant difference for ADA levels between the benign and low-grade malignant tumors. There was an important correlation between the peritoneal fluid and serum ADA levels.


Serum and peritoneal fluid ADA levels were found to be higher in malignant ovarian neoplasms. This finding may be useful to understand the biochemically characteristics of malignant ovarian tumors and ADA may be a useful biomarker in diagnosis and management of ovarian tumors.


Adenosine deaminase (ADA) Benign ovarian neoplasm Ovarian cancer Peritoneal fluid 



We thank to Prof. Dr. Eren Erken for her competent advices on the stage of writing this article and Immunology Laboratory Technicians for ADA analysis.

Conflict of interest



  1. 1.
    Rein BJ, Gupta S, Dada R, Safi J, Michener C, Agarwal A (2011) Potential markers for detection and monitoring of ovarian cancer. J Oncol 2011. Art no 475983. doi: 10.1155/2011/475983
  2. 2.
    Gakis C (1996) Adenosine deaminase (ADA) isoenzymes ADA1 and ADA2: diagnostic and biological role. Eur Respir J 9:623–624CrossRefGoogle Scholar
  3. 3.
    Gupta BK, Bharat V, Bandyopadhyay D (2010) Sensitivity, specificity, negative and positive predictive values of adenosine deaminase in patients of tubercular and non-tubercular serosal effusion. India J Clin Med Res 2(3):121–126Google Scholar
  4. 4.
    Aghaei M, Karami-Tehrani F, Salami S, Atri M (2005) Adenosine deaminase activity in the serum and malignant tumors of breast cancer: The assessment of isoenzyme ADA1 and ADA2 activities. Clin Biochem 38:887–891PubMedCrossRefGoogle Scholar
  5. 5.
    Eroglu A, Canbolat O, Demirci S, Kocaoglu H, Eryavuz E, Akgul H (2000) Activities of adenosine deaminase and 5′ nucleotidase in cancerous and noncancerous human colorectal tissues. Med Oncol 17:319–324PubMedCrossRefGoogle Scholar
  6. 6.
    Buyukberber M, Sevinc A, Cagliyan CE, Gulsen MT, Sari I, Camci C (2006) Non-Hodgkin lymphoma with high adenosine deaminase levels mimicking peritoneal tuberculosis: an unusual presentation. Leuk Lymphoma 47(3):565–568PubMedCrossRefGoogle Scholar
  7. 7.
    Bilgin T, Karabay A, Dolari E, Develioglu OH (2001) Peritoneal tuberculosis with pelvic abdominal mass, ascites and elevated CA 125 mimicking advanced ovarian carcinoma: a series of 10 cases. Int J Gynecol Cancer 11:290–294PubMedCrossRefGoogle Scholar
  8. 8.
    Guirat A, Koubaa M, Mzali R, Abid B, Ellouz S, Affes N, Ben Jemaa M, Frikha F, Ben Amar M, Beyrouti MI (2011) Peritoneal tuberculosis. Clin Res Hepatol Gastroenterol 35(1):60–69PubMedCrossRefGoogle Scholar
  9. 9.
    Liang QL, Shi HZ, Wang K, Qin SM, Qin XJ (2008) Diagnostic accuracy of adenosine deaminase in tuberculous pleurisy: a meta-analysis. Respir Med 102:744–754PubMedCrossRefGoogle Scholar
  10. 10.
    Pavlik EJ, DePriest PD, Gallion HH, Ueland FR, Reedy MB, Kryscio RJ, van Nagell JR (2000) Ovarian volume related to age. Gynecol Oncol 77:410–412PubMedCrossRefGoogle Scholar
  11. 11.
    Giusti G (1974) Adenosine deaminase. In: Bergmeyer H (ed) Methods of enzymatic analysis. Academic Press, New York, pp 1092–1099Google Scholar
  12. 12.
    Motherby H, Nadjari B, Friegel P, Kohaus J, Ramp U, Böcking A (1999) Diagnostic accuracy of effusion cytology. Diagn Cytopathol 20:350–357PubMedCrossRefGoogle Scholar
  13. 13.
    Camici M, Tozzi MG, Allergrini S, Del Corso A, Sanfilippo O, Daidone MG, De Marco C, Ipata PL (1990) Purine salvages enzyme activities in normal and neoplastic human tissues. Cancer Biochem Biophys 11:201–209PubMedGoogle Scholar
  14. 14.
    Biri H, Ozturk HS, Kacmaz M, Karaca K, Tokucoglu H, Durak I (1999) Activity of DNA turnover and free radical metabolizing enzymes in cancerous human prostate tissue. Cancer Invest 17:314–319PubMedCrossRefGoogle Scholar
  15. 15.
    Vannoni D, Bernini A, Carlucci F, Civitelli S, Di Pietro MC, Leoncini R, Rosi F, Tabucchi A, Tanzini G, Marinello E (2004) Enzyme activity controlling adenosine levels in normal and neoplastic tissues. Med Oncol 21:187–195PubMedCrossRefGoogle Scholar
  16. 16.
    Aghaei M, Karami-Tehrani F, Salami S, Atric M (2010) Diagnostic Value of Adenosine Deaminase Activity in Benign and Malignant Breast Tumors. Arch Med Res 41:14–18PubMedCrossRefGoogle Scholar
  17. 17.
    Barry CP, Lind SE (2000) Adenosine-mediated killing of cultured epithelial cancer cells. Cancer Res 60(7):1887–1894PubMedGoogle Scholar
  18. 18.
    Sari RA, Taysi S, Yilmaz O, Bakan N (2003) Correlation of serum levels of adenosine deaminase activity and its isoenzymes with disease activity in rheumatoid arthritis. Clin Exp Rheumatol 21(1):87–90PubMedGoogle Scholar
  19. 19.
    Yoneyama Y, Swa R, Suzuki S, Otsubo Y, Araki T (2002) Serum adenosine deaminase activity in women with hyperemesis gravidarum. Clin Chem Acta 324:141–145CrossRefGoogle Scholar
  20. 20.
    Yoneyama Y, Sawa R, Suzuki S, Otsubo Y, Miura A, Kuwabara Y, Ishino H, Kiyokawa Y, Doi D, Yoneyama K, Kobayashi H, Araki T (2002) Serum adenosine deaminase activity in women with pre-eclampsia. Gynecol Obstet Invest 54(3):164–167PubMedCrossRefGoogle Scholar
  21. 21.
    Hitoglou S, Zournatzi V, Gougoustamou D, Hatzistilianou M, Tzafettas J (2004) Adenosine deaminase activity and its isoenzyme pattern in women with recurrent spontaneous abortions. Gynecol Obstet Invest 58(3):126–129PubMedCrossRefGoogle Scholar
  22. 22.
    Riquelme A, Calvo M, Saleh F, Valderrama S, Pattillo A, Arellano M, Arrese M, Soza A, Viviani P, Letelier LM (2006) Value of adenosine deaminase (ADA) in ascitic fluid for the diagnosis of tuberculous peritonitis: a meta-analysis. J Clin Gastroenterol 40:705–710PubMedCrossRefGoogle Scholar
  23. 23.
    Zarić B, Kuruc V, Milovancev A, Markovic M, Sarcev T, Canak V, Pavlović S (2008) Differential diagnosis of tuberculous and malignant pleural effusions: what is the role of adenosine deaminase? Lung 186(4):233–240PubMedCrossRefGoogle Scholar
  24. 24.
    Adali E, Dulger C, Kolusari A, Kurdoglu M, Yildizhan R (2009) Pelvic-peritoneal tuberculosis simulating peritoneal carcinomatosis: high clinical suspicion and a minimally invasive procedure. Arch Gynecol Obstet 280:867–868PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2012

Authors and Affiliations

  • Ibrahim Ferhat Urunsak
    • 1
  • Umran Kucukgoz Gulec
    • 1
  • Semra Paydas
    • 2
  • Gulsah Seydaoglu
    • 3
  • Ahmet Baris Guzel
    • 1
  • Mehmet Ali Vardar
    • 1
  1. 1.Department of Obstetrics and Gynecology, School of MedicineCukurova UniversityAdanaTurkey
  2. 2.Department of Medical Oncology, School of MedicineCukurova UniversityAdanaTurkey
  3. 3.Department of Biostatistics, School of MedicineCukurova UniversityAdanaTurkey

Personalised recommendations